Low Seroprevalence among Undetected COVID-19 Cases, Faroe Islands, November 2020
Maria Skaalum Petersen
, Marin Strøm, Jógvan Páll Fjallsbak, Jóhanna Ljósá Hansen, Sólrun Larsen, Eina H. Eliasen, Malan Johansen, Anna Sofía Veyhe, Marnar Fríðheim Kristiansen, and Pál Weihe
Author affiliations: The Faroese Hospital System, Tórshavn, Faroe Islands (M.S. Petersen, E.H. Eliasen, M. Johansen, A.S. Veyhe, P. Weihe); University of the Faroe Islands, Tórshavn (M.S. Petersen, M. Strøm, E.H. Eliasen, M. Johansen, A.S. Veyhe, M.F. Kristiansen, P. Weihe); Faroese Food and Veterinary Authority, Tórshavn (J.P. Fjallsbak, J.L. Hansen, S. Larsen); National Hospital of the Faroe Islands, Tórshavn (M.F. Kristiansen)
Figure. Flowchart of participant recruitment for severe acute respiratory syndrome coronavirus 2 seroprevalence study, Faroe Islands, November 2020. *Persons previously diagnosed with COVID-19 were excluded from serosurvey but included in the total number of cases. COVID-19, coronavirus disease.
Page created: October 08, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.